أعرض في EDS

High Rates of Transplantation in the Phase III Sierra Trial Utilizing Anti-CD45 (Iodine) 131I-Apamistamab (Iomab-B) Conditioning with Successful Engraftment and Tolerability in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) Patients after Lack of Response to Conventional Care and Targeted Therapies

التفاصيل البيبلوغرافية
العنوان: High Rates of Transplantation in the Phase III Sierra Trial Utilizing Anti-CD45 (Iodine) 131I-Apamistamab (Iomab-B) Conditioning with Successful Engraftment and Tolerability in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) Patients after Lack of Response to Conventional Care and Targeted Therapies
المؤلفون: Boglarka Gyurkocza, Rajneesh Nath, Stuart E. Seropian, Hannah Choe, Mark R. Litzow, Nebu Koshy, Patrick Stiff, Camille Abboud, Benjamin Tomlinson, Sunil Abhyankar, Parameswaran Hari, George L Chen, Zaid Al-Kadhimi, Mitchell Sabloff, Johnnie J. Orozco, James Foran, Partow Kebriaei, Katarzyna Jamieson, Margarida Magalhaes-Silverman, Koen van Besien, Michael W Schuster, Arjun Datt Law, Moshe Yair Levy, Hillard M. Lazarus, Sergio A Giralt, Mark S. Berger, Jennifer Spross, Avinash Desai, Vijay Reddy, John M. Pagel
المصدر: Transplantation and Cellular Therapy. 28:S35-S36
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
تدمد: 2666-6367
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::654dc8fe305778b2b6e113143533f0e7
https://doi.org/10.1016/s2666-6367(22)00201-9
حقوق: OPEN
رقم الأكسشن: edsair.doi...........654dc8fe305778b2b6e113143533f0e7
قاعدة البيانات: OpenAIRE
الوصف
تدمد:26666367